Status:
COMPLETED
(In)Voluntary Assessed Quadriceps Muscle Endurance in COPD
Lead Sponsor:
Radboud University Medical Center
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
40-80 years
Brief Summary
The primary objective is to assess the relation between involuntary and voluntary assessed quadriceps muscle endurance in patients with COPD. We hypothesized a good correlation (\>0.8) between the mea...
Detailed Description
Rationale: Quadriceps muscle endurance is reduced in patients with COPD. However, no consensus has been reached yet on the best method to evaluate quadriceps muscle endurance. One important aspect is ...
Eligibility Criteria
Inclusion
- COPD, based on GOLD classification
- Clinically stable according to the pulmonary physician, i.e. no exacerbation and/or hospitalization within the previous 4 weeks
- Age between 40-80 years
- Take part in the pulmonary rehabilitation program at Radboudumc (Nijmegen)
Exclusion
- Inability to understand the Dutch language
- Musculoskeletal and neurological problems influencing quadriceps muscle function testing
Key Trial Info
Start Date :
July 5 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 20 2023
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT05427773
Start Date
July 5 2022
End Date
January 20 2023
Last Update
February 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525 GA